Covidien Stapler Malfunctioned During Surgery, Leading to Tissue Damage and Hospitalization: Lawsuit

Lawsuit indicates design defects caused stapler to malfunction, resulting in numerous injuries, long-term hospitalization and weeks of rehabilitation and home health care

Medtronic and it’s Covidien subsidiary face a product liability lawsuit filed by a North Carolina woman, who indicates she was left with severe injuries when a surgical stapler malfunctioned, resulting in tissue damage and the need for additional surgeries.

The complaint (PDF) was filed by Kimberly Bell in Massachusetts federal court on September 9, indicating that an Endo GIA 45mm stapler with Tri Staple Technology malfunctioned during surgery, causing a “tear” in the surgical area, leading to prolonged hospitalization and extensive medical care.

The case joins a growing number of surgical stapler lawsuits being pursued against Covidien and other manufacturers, each raising similar allegations that design defects caused the devices to misfire, fail to fire or issue malformed staples, which can cause devastating internal injuries and organ perforations.

Learn More About

Surgical Staplers Lawsuits

Problems with surgical staplers may result in devastating injuries from internal surgery staples. Lawyers review cases nationwide.


The lawsuit indicates Bell underwent a laparoscopic biliopancreatic diversion and hernia repair in September 2019, at which time the Covidien stapler malfunctioned. Following additional surgical procedures to repair the damage, Bell indicates she suffered nausea, vomiting and hypertension, followed by shortness of breath and worsening abdominal pain, as well as poor urinary output. She then became hypotensive, suffering from low blood pressure. She was diagnosed as suffering an anastomotic leak due to a tear at the apex staples, measuring 5 mm.

“This anastomotic leak led to Ms. Bell’s development of acute respiratory failure and pulmonary edema leading to septic shock,” the lawsuit states. “After her procedure on September 14, 2019, Ms. Bell was transferred to the critical unit for medical intensive care and vent management, Ms. Bell was on a ventilator for seven (7) days. She required several liters of Lactated Ringer’s solution and developed acute kidney injury which required her to start intermittent hemodialysis.”

Later that month she suffered atrial fibrillation, and spent a total of 30 days in the hospital, including two weeks in critical care and another week on a ventilator. She was then released to a rehabilitation facility for another two weeks, followed by about two weeks of home health care.

Surgical Stapler Problems

In March 2019, the FDA reported at least 41,000 adverse event reports involving surgical stapler failures were filed between January 2011 and March 2018, including 366 patient deaths. However, it appears that those reports did not include all problems linked to the devices.

As part of an effort to make surgical staplers safer, the FDA issued new rules and guidelines for Covidien and other manufacturers, and has to reclassified staplers as Class II surgical devices, which now requires any new surgical staplers to undergo premarket review before getting FDA approval.

The change of surgical staplers from class I medical device (general controls) to class II medical devices (special controls) has been anticipated for several years, and does not affect the classification of the staples themselves. However, it would require more stringent premarket approval for new staplers and force manufacturers to provide more thorough safety warnings and instructions.


  • CynthiaApril 6, 2024 at 6:57 pm

    Covidien 28 mm stapler recall?

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal (Posted yesterday)

A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.

Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October
Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October (Posted yesterday)

A U.S. District Court judge has scheduled a fairness hearing for October in order to determine whether final approval should be granted to a $25 million Philips CPAP recall settlement agreement, which would pay former users $25 million to pay for future medical monitoring needs.

Abbott Laboratories Faces Jury Trial Over Claims Similac Caused NEC For Premature Infant
Abbott Laboratories Faces Jury Trial Over Claims Similac Caused NEC For Premature Infant (Posted 2 days ago)

Following a $60 million verdict in a similar lawsuit earlier this year, trial is underway involving claims brought by an Illinois mother, whose premature daughter developed NEC from Similac, alleging that Abbott failed to warn parents and medical staff of the devastating risks associated with the cow's milk-based formula.